Pressroom: Media Coverage

Showing 101 - 120 of 609 news items


Drug Development: Releasing the Brakes

Immunologist Jedd Wolchok commented on new therapies called immune checkpoint blockades that free immune cells to attack cancer.

December 18, 2013
Hormone Used for Doping Is Made from Scratch

Research led by chemist Samuel Danishefsky has synthesized for the first time erythropoietin, the hormone that controls the production of red blood cells.

December 12, 2013
The Best and Worst Health Trends of 2013

Gynecologic surgeon Carol Brown discussed the benefits of the HPV vaccine.

December 11, 2013
Cancer Progress Threatened by Budget Cuts in Congress, Group Says

Medical oncologist Clifford Hudis stressed the need for more research funding to continue making progress in the fight against cancer.

December 10, 2013
Killing Cancer like the Common Cold

Physician-scientist Renier Brentjens commented on promising results of three separate studies of immunotherapies for leukemia.

December 9, 2013
Hopes Raised for Simplification of Cancer Research

Cancer biologist Joan Massagué who was recently named Director of the Sloan-Kettering Institute answered questions about the areas of cancer research that excite him.

December 9, 2013
Real Estate And Media Mogul Mort Zuckerman Continues To Spread His Influence Across New York And The World

Memorial Sloan-Kettering board member Mortimer Zuckerman was interviewed about his philanthropy, including his generous gift to Memorial Sloan-Kettering to construct the Mortimer B. Zuckerman Research Center.

December 9, 2013
Health Problems Common in Survivors of Pediatric Cancer

Internist Emily Tonorezos discussed some of the health issues survivors of pediatric cancer face.

December 8, 2013
Cancer Survivors Celebrate Their Cancerversary

Memorial Sloan-Kettering patient Bruce Feiler reflected on the five year anniversary of his cancer diagnosis. His surgeon John Healey was quoted.

December 7, 2013
Cancer Centers, Longtime Rivals, Launch Company to Develop New Drug

Memorial Sloan-Kettering has partnered with the Fred Hutchinson Cancer Research Center and the Seattle Children’s Research Institute to form a biotechnology company to speed the development of novel immunotherapies for cancer. Cell researchers Michel Sadelain, Isabelle Rivière, and Renier Brentjens are co-founders.

December 4, 2013
Dr. van den Brink on Adding Ibrutinib to R-CHOP in NHL

Hematologic Oncology Division Head Marcel van den Brink discusses a trial that analyzes the addition of ibrutinib to R-CHOP in patients with non-Hodgkin lymphoma. The trial will be presented at the 2013 American Society of Hematology Annual Meeting and Exposition.

December 4, 2013
ASH 2013 Preview: CAR Modified T Cells, Novel Assays, and Ibrutinib

Hematologic Oncology Division Head Marcel van den Brink comments on abstracts being presented by Memorial Sloan Kettering physicians at the 2013 American Society of Hematology Annual Meeting and Exposition.

December 4, 2013
Mammograms in 3-D May Be Better, but Hard Proof is Missing

Radiologist Carol Lee discussed the benefits and harms of 3-D mammography.

December 3, 2013
Signs of Aging, Even in the Embryo

Biologist Scott Lowe commented on new research that found senescent cells – cells that stop dividing over time – in embryos.

November 21, 2013
Vows: In Sickness and In Health

Memorial Sloan Kettering patient Virginia Wettlaufer was diagnosed with breast cancer six months after she and Walter Tomenson started dating. Her care team shared words of encouragement to the happy couple, who recently exchanged vows.

November 16, 2013
Why Mammogram Guidelines Would Have Missed Amy Robach's Cancer

Medical oncologist Larry Norton commented on the importance of early breast cancer screening.

November 13, 2013
Advocates Push for Straight Talk About Sex for Cancer Patients

Medical oncologist Shari Goldfarb spoke about the sexual side effects of cancer and its treatment.

November 12, 2013
Breakthroughs in Animal Healthcare May Hold Treatments for Humans

Medical oncologist Larry Norton spoke about the collaboration among physicians and veterinarians to fight diseases affecting both animals and humans.

November 5, 2013
Doctors Fear Losing Leukemia Drug Deemed Risky

Medical oncologist Michael Mauro commented on an FDA decision to ban the sale of a leukemia drug that has been keeping patients alive but also comes with serious side effects.

November 2, 2013
Cancer Survivor's Mom Gives NYC Marathon 2nd Try After Hurricane Sandy

Fred’s Team runner Danielle Kelly ran the ING New York City Marathon for her daughter, Maggie, who was treated for neuroblastoma at Memorial Sloan Kettering.

November 1, 2013